Dimensional Fund Advisors’s Cocrystal Pharma COCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,092
Closed -$21K 3289
2025
Q2
$21K Sell
14,092
-504
-3% -$750 ﹤0.01% 3268
2025
Q1
$20.7K Sell
14,596
-419
-3% -$782 ﹤0.01% 3302
2024
Q4
$30.3K Buy
15,015
+923
+7% +$1.85K ﹤0.01% 3314
2024
Q3
$24.8K Buy
+14,092
New +$27.4K ﹤0.01% 3327
2022
Q1
Sell
-2,685
Closed -$21K 3520
2021
Q4
$21K Hold
2,685
﹤0.01% 3527
2021
Q3
$34K Sell
2,685
-9,019
-77% -$119K ﹤0.01% 3486
2021
Q2
$176K Sell
11,704
-4,186
-26% -$63.6K ﹤0.01% 3358
2021
Q1
$265K Hold
15,890
﹤0.01% 3243
2020
Q4
$259K Hold
15,890
﹤0.01% 3192
2020
Q3
$177K Buy
+15,890
New +$290K ﹤0.01% 3215
2019
Q4
Sell
-9,182
Closed -$225K 3387
2019
Q3
$225K Hold
9,182
﹤0.01% 3264
2019
Q2
$259K Buy
9,182
+3,168
+53% +$94.1K ﹤0.01% 3284
2019
Q1
$197K Buy
6,014
+3,238
+117% +$118K ﹤0.01% 3313
2018
Q4
$120K Buy
2,776
+1,872
+207% +$61.7K ﹤0.01% 3344
2018
Q3
$27K Buy
+904
New +$40.4K ﹤0.01% 3412

Other funds holding COCP

Dimensional Fund Advisors's COCP Position: Q3 2025 in Review

Dimensional Fund Advisors sold out of Cocrystal Pharma (COCP) in Q3 2025, closing a stake of 14,092 shares — an estimated $21K sold.

Dimensional Fund Advisors first reported a position in COCP in Q3 2018 and held it in 15 quarters. The position peaked at $265K in Q1 2021. 22 funds tracked by Wall St. Rank hold COCP as of Q3 2025.

  • Dimensional Fund Advisors reported no remaining Cocrystal Pharma position as of Q3 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 14,092 Cocrystal Pharma shares in Q3 2025, an estimated $21K.
  • Dimensional Fund Advisors first reported a position in Cocrystal Pharma in Q3 2018 and held it in 15 quarters.
  • Dimensional Fund Advisors's Cocrystal Pharma position peaked at $265K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2025.

Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.